AT
GILD icon

Argent Trust’s Gilead Sciences GILD Stock Holding History

Argent Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$2.58M Sell
34,267
-584
-2% -$46.4K 0.71% 44
2017
Q4 		$2.5M Sell
34,851
-975
-3% -$74K 0.67% 44
2017
Q3 		$2.9M Buy
35,826
+73
+0.2% +$5.58K 0.79% 38
2017
Q2 		$2.53M Buy
35,753
+1,228
+4% +$81.7K 0.71% 47
2017
Q1 		$2.35M Buy
34,525
+2,215
+7% +$156K 0.66% 45
2016
Q4 		$2.31M Buy
32,310
+5,699
+21% +$424K 0.67% 46
2016
Q3 		$2.1M Buy
26,611
+6,070
+30% +$493K 0.64% 47
2016
Q2 		$1.71M Buy
20,541
+1,997
+11% +$177K 0.53% 58
2016
Q1 		$1.7M Buy
18,544
+2,372
+15% +$214K 0.55% 52
2015
Q4 		$1.64M Buy
16,172
+12,453
+335% +$1.3M 0.54% 58
2015
Q3 		$365K Sell
3,719
-225
-6% -$25K 0.41% 57
2015
Q2 		$462K Sell
3,944
-85
-2% -$9.29K 0.45% 47
2015
Q1 		$395K Sell
4,029
-87
-2% -$8.83K 0.39% 55
2014
Q4 		$388K Buy
+4,116
New +$426K 0.35% 58

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Argent Trust's GILD Position: Q1 2018 in Review

Argent Trust reduced its Gilead Sciences (GILD) stake by 1.7% in Q1 2018, selling an estimated $46.4K and leaving 34,267 shares worth $2.58M. The position accounts for 0.71% of the portfolio, ranked #44.

Argent Trust first reported a position in GILD in Q4 2014 and has held it in 14 quarters since. The position peaked at $2.9M in Q3 2017. 1,563 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • Argent Trust held 34,267 shares of Gilead Sciences worth $2.58M as of Q1 2018.
  • Argent Trust sold 584 Gilead Sciences shares in Q1 2018, an estimated $46.4K.
  • Gilead Sciences made up 0.71% of Argent Trust's portfolio in Q1 2018, its #44 holding.
  • Argent Trust first reported a position in Gilead Sciences in Q4 2014 and has held it in 14 quarters since.
  • Argent Trust's Gilead Sciences position peaked at $2.9M in Q3 2017.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on Argent Trust's 13F filing for Q1 2018, filed 11 May 2018.